36C24624Q0349_1.docx

DOCX document 16 KB Posted

Attached to
Q301--Oncotype DX Medical Laboratory Testing Notice of Intent to Sole Source
Solicitation number
36C24624Q0349
Issued by

About this file

This special notice from the Department of Veterans Affairs announces a sole source award for Oncotype DX medical laboratory testing. The Durham VAMC will negotiate a firm-fixed price BPA with Exact Sciences Corporation for Oncotype DX Breast Tests from March 6, 2024 to March 5, 2025. Interested parties must identify their capability by February 27 at 11:00 AM EST to contract specialist Daleta Coles. The Oncotype test uses real-time RT-PCR to analyze 21 genes in a tumor sample and determine the recurrence score, detailing the composition of an individual's specific tumor. The Durham VAMC requires these unique, highly specialized services which are only available from Exact Sciences on their FSS contract and cannot be met by other distributors, SDVOSBs, or VOSBs to satisfy the agency's needs per FAR 13.106-1(b)(1).

View the file

Other files

File Type Posted
Limiting Sources Justification Oncotype Testing.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Special Notice Special Notice

SUBJECT*
Oncotype DX Medical Laboratory Testing Notice of Intent to Sole Source

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
23667
SOLICITATION NUMBER*
36C24624Q0349
RESPONSE DATE/TIME/ZONE
02-27-2024 11:00 EASTERN TIME, NEW YORK, USA
ARCHIVE
30 DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
N
PRODUCT SERVICE CODE*
Q301
NAICS CODE*
541380

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs Network Contracting Office 6 100 Emancipation Drive Hampton VA 23667

POINT OF CONTACT*

Contracting Officer Daleta Coles daleta.coles@va.gov 757-722-9961 ext-3115

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

The Department of Veteran Affairs, Veterans Health Administration, Network Contracting Office 6, Hampton VA 23667, intends to negotiate a new BPA, sole source, firm-fixed price contract for the Durham VAMC laboratories to Exact Sciences Corporation for Oncotype DX Breast Tests with 41 U.S.C. §3304(a)(1) as implemented by FAR 6.302-1 Only One Responsible Source.

This is not a request for competitive offers and no solicitation is available. Market research has determined that these items are highly specialized, are only available from a single source without an unacceptable delay or duplication of cost and no other type of items will satisfy agency requirements. The Government intends to award the contract with an effective date of 06 March 2024 to Exact Sciences Corporation, 5505 Endeavor Lane, Madison, WI 53719; Unique Entity ID: NGBXEJX5GLE9.

This is a Brand-Name Only requirement for Durham VAMC laboratories. The Durham VAMC require supplies and services that are unique and highly specialized The Oncotype test use mRNA, real time RT-PCR of 21 genes to process and report the specific tumor’s recurrence score, which details the composition of an individual’s specific tumor. The required services are available on FSS contract and not available through any other distributor, SDVOSB or VOSB. No other supplies or services will satisfy agency requirements per FAR 13.106-1(b)(1).

This synopsis announcement is being issued for information purposes only and does not constitute a solicitation or request for competitive proposals. If a firm believes it is capable of meeting the Government's requirement, it may identify its interest and capability to the contract specialist within three (3) calendar days of this publication by contacting Daleta Coles via e-mail at daleta.coles@va.gov Telephone inquiries will not be accepted. This announcement closes 27 February 2024 at 11:00 AM EST. Those interested firms must indicate whether they are large, small, small-disadvantaged, 8(a) or woman owned business and whether they are U.S. or foreign owned. Respondents who submit proprietary data shall clearly mark the data with appropriate markings. The Government will not pay for any information submitted as a result of this synopsis. This synopsis shall not be construed as an obligation on the part of the Government to acquire any products or services.

***Reference RFP 36C24624Q0349 in all replies

See attached document: Limiting Sources Justification Oncotype Testing.

*= Required Field
Special Notice

Special Notice

File details come from the government source that posted it. Updated .